We then examined the potential of identified PCNA-binding NKp44-derived peptides, conjugated to cell-penetrating moieties, to (i) inhibit cancer cell proliferation or induce apoptosis in vitro and (ii) mediate tumor growth arrest in vivo, in several mouse and human cancer cell lines. Here, NCR2 is linked to neoplasm.